Truist Cuts PT on Aveanna Healthcare Holdings Inc. (AVAH) to $8 From $9

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) is one of the most oversold healthcare stocks to invest in. Truist cut the price target on Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) to $8 from $9 on April 13 and reiterated a Hold rating on the shares. The rating update came as part of a broader research note previewing Q1 results in Healthcare Services, or HC, with the firm remaining broadly bullish on its HC Services coverage universe. This is primarily because of factors such as continued strong demand trends, overarching secular tailwinds, and a more favorable/stable reimbursement backdrop. It also sees the recent Final Medicare Advantage Rule as an “encouraging data point”.

Truist further told investors in a research note that it continues to see the sector as well-positioned, given that it’s scaled, domestic, and defensive, adding that the group is also a beneficiary of AI/automation/interconnectivity, with strong free cash flow and attractive financial flexibility supporting the ongoing growth, investment/M&A/shareholder friendly initiatives.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) provides home care services to patients. The company’s operations are divided into the following business segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS).

While we acknowledge the risk and potential of AVAH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AVAH and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.